Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eine Phase II Studie Zur Beurteilung Der Wirksamkeit Von Rituximab in Der Salvage- Und Hochdosistherapie Mit Autologer Stammzelltransplantation Bei Patienten Mit B-Zell-Non-Hodgkin-Lymphom

NCT02099292 is registered in ClinicalTrials.gov with Georg Hess, MD as lead sponsor.

NCT NCT02099292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02099292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eine Phase II Studie Zur Beurteilung Der Wirksamkeit Von Rituximab in Der Salvage- Und Hochdosistherapie Mit Autologer Stammzelltransplantation Bei Patienten Mit B-Zell-Non-Hodgkin-Lymphom
Lead sponsor
Georg Hess, MD
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2001
Completion date
March 31, 2014
Enrollment
103 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed non-hodgkin-lymphoma